Clinical Trials Logo

Filter by:
NCT ID: NCT05621629 Completed - Fecal Incontinence Clinical Trials

Management of FI After Surgery of ARM

Start date: September 1, 2022
Phase:
Study type: Observational

The posterior sagittal approach to anorectal malformation (ARM) has radically changed the outcome of these patients, improving the preservation of anal sphincters, owing to their anatomical identification. However, in long term follow-up, fecal incontinence and severe constipation remain the most frequent and disabling postoperative clinical problems, having a significant influence on quality of life. Current therapeutic measures for Fecal Incontinence include biofeedback, sacral nerve stimulation, radiofrequency energy delivery, surgical treatment and sphincter replacement. Biofeedback combined with SNS has achieved satisfactory results. However, not all patients have an improvement in their weakened anal sphincter and achieve acceptable continence. A detailed assessment of anorectal sphincter morphology and function can predict therapeutic outcome. Magnetic resonance imaging(MRI) can help to judge the anal atresia type, to display the presence and running of the fistula, and to show the nature of anal sphincter, such as the shape, thickness, directions and position of the anal sphincter complex and location in the pelvic floor and other systems malformations, finally to provide a reliable diagnostic basis for surgical program and prognostic assessment. High-resolution anorectal manometry (HR-ARM) is the latest internationally recognized examination for the evaluation of anorectal function. A standardised protocol of HR-ARM can characterise FI from dyssynergic or other neuromuscular and sensory problems. As a result, HR-ARM provides a more appropriate management in patients with FI. In order to assess whether patients with fecal incontinence should choose biofeedback therapy, our study included children with FI after anorectal malformation, and combined HR-ARM and MR to predict the efficacy of sacral nerve stimulation and pelvic floor rehabilitation.

NCT ID: NCT05621330 Completed - Clinical trials for Primary Immune Thrombocytopenia

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Start date: October 18, 2019
Phase: Phase 3
Study type: Interventional

QL0911, a recombinant human thrombopoietin mimetic peptide-Fc fusion protein for injection, is a romiplostim (Nplate®) biosimilar for the treatment of primary immune thrombocytopenia (ITP). This phase III study aimed to assess the efficacy and safety of QL0911 in adult patients with primary chronic ITP.

NCT ID: NCT05620537 Completed - Prognosis Clinical Trials

A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients

Start date: November 10, 2022
Phase:
Study type: Observational

This multicenter retrospectively observational cohort study was conducted on participants with histologically confirmed gastric and colorectal cancer who underwent radical surgery in 11 medical centers in China from August 1, 2015, to June 31, 2018. Baseline clinicopathologic data and nutritional status assessments including Nutrition Risk Screening 2002 (NRS 2002) score and Patient-generated Subjective Global Assessment (PG-SGA) rating were collected. Variables will be screened using the least absolute shrinkage and selection operator (LASSO) regression model and Cox regression analysis. Internal and external validations will be performed via the receiver operating curve (ROC), the area under the curve (AUC), the concordance index (C-index), calibration plots, decision curve analysis (DCA), and Five folds cross-validation by 200 times.

NCT ID: NCT05620160 Completed - Clinical trials for Mild to Moderate COVID-19

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

Start date: November 12, 2022
Phase: Phase 3
Study type: Interventional

This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of RAY1216 tablets in the treatment of mild to moderate SARS-CoV-2 infection. The total study duration is up to 28 days.

NCT ID: NCT05620056 Completed - Pregnancy Clinical Trials

A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP)

Start date: January 1, 2013
Phase:
Study type: Observational

The DEEP cohort is the first population-based cohort of pregnant population in China that longitudinally documents drug uses throughout the pregnancy life course and adverse pregnancy outcomes.

NCT ID: NCT05619926 Completed - Hemophilia Clinical Trials

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Start date: January 9, 2023
Phase: Phase 2
Study type: Interventional

This study will assess the safety,efficacy,pharmacokinetics and pharmacodynamics of multiple-dose of STSP-0601 at two dose levels for the treatment of bleeding episodes in hemophilia A or B patients without inhibitor.

NCT ID: NCT05619848 Completed - Clinical trials for Spinal Stenosis Lumbar

Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery

RUILS
Start date: October 25, 2022
Phase: Early Phase 1
Study type: Interventional

To investigate the effect of different degrees of fat infiltration on rocuronium use in lumbar surgery was monitored by trapezius muscle relaxation.

NCT ID: NCT05618535 Completed - Clinical trials for Acute Ischemic Stroke

Effect of Body Position on Hemodynamics in Patients With Acute Ischemic Stroke Undergoing Ultra-early Reperfusion Therapy

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study was to determine the differences in hemodynamics between different positions in patients undergoing ultra-early reperfusion therapy.

NCT ID: NCT05617573 Completed - Clinical trials for Osteoarthritis, Knee

Synovitis in Patients With Osteoarthritis

Start date: November 1, 2020
Phase:
Study type: Observational

To study synovial membrane (SM) inflammation in suprapatellar fossa in advanced knee osteoarthritis (OA), and to correlate the pathological features with clinical findings.

NCT ID: NCT05617352 Completed - Esophageal Cancer Clinical Trials

The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study

Start date: May 1, 2022
Phase:
Study type: Observational

To clarify the effect of Two-field or Three-field Lymphadenectomy on the survival of esophageal squamous cell carcinoma.